Cyanotech Corp. (CYAN) intrinsic value & 10-year financials

Cyanotech Corp. (CYAN) has a Graham intrinsic value of $0.75 per share. At $0.70 on Oct 17, 2026, the stock trades 7% below that value. Over the last 10 fiscal years revenue shrank 3.0% a year to $24.2M, with an average return on invested capital of -4.3%.

Graham intrinsic value
$0.75
Share price (Oct 17, 2026)
$0.70
Price vs Graham value
7% below
Market cap
$4.6K
Revenue (FY2025)
$24.2M
Revenue growth (10-yr CAGR)
-3.0%
ROIC (10-yr avg)
-4.3%
Free cash flow (FY2025)
—

CYAN 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $24.2M -$3.2M — — -10.4% -13.4%
FY2024 $23.1M -$5.3M -$0.81 — -19.9% -19.3%
FY2023 $23.2M -$3.4M -$0.55 — -12.6% -11.4%
FY2022 $36.0M $2.2M $0.35 — 7.2% 10.5%
FY2021 $32.3M $920.0K $0.15 — 0.3% 0.3%
FY2020 $31.9M $387.0K $0.06 — 3.3% 4.5%
FY2019 $30.2M -$3.6M -$0.62 -$1.3M -9.9% -13.8%
FY2018 $34.1M $1.0M $0.18 $485.0K 4.1% 6.2%
FY2017 $32.0M -$1.2M -$0.21 $373.0K -2.1% -2.9%
FY2016 $31.8M -$4.4M -$0.79 -$3.6M -2.5% -3.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

CYANOTECH CORP is facing top-line stagnation, with revenue contracting over the decade.

CYANOTECH CORP has historically struggled to out-earn its cost of capital, averaging just -4.3% ROIC.

CYANOTECH CORP has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, CYANOTECH CORP is modeled at -3.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.75 per share.

CYAN stock: frequently asked questions

What is the intrinsic value of Cyanotech Corp. (CYAN) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -3.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, CYAN's intrinsic value is about $0.75 per share.

Is CYAN stock undervalued?

At $0.70 (close on Oct 17, 2026), CYAN trades 7% below its Graham value of $0.75. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Cyanotech Corp. grown?

Revenue went from $31.8M in fiscal 2016 to $24.2M in fiscal 2025, a compound annual growth rate of -3.0%. Net income was -$3.2M in fiscal 2025.

What is CYAN's return on invested capital?

Average ROIC over the last 10 fiscal years was -4.3%, and average return on equity was -11.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CYAN data come from?

From Cyanotech Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Nov 10, 2025. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medicinal chemicals & botanical products stocks